Technology Innovations and Growth Opportunities for COVID-19, Digital Pathology, Cancer, Stress, Pain, and Obesity

Technology Innovations and Growth Opportunities for COVID-19, Digital Pathology, Cancer, Stress, Pain, and Obesity

RELEASE DATE
24-Apr-2020
REGION
Global
Research Code: D759-00-13-00-00
SKU: HC03285-GL-TA_24340

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03285-GL-TA_24340

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses recent innovations in life sciences, health & wellness. The research encompasses recent advances across digital pathology, COVID-19 management, cancer treatment, pain therapy, and an obesity drug among several other innovations. The TOE also provides valuable growth opportunities within each innovation landscape.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Dyskinesia, artificial intelligence, digital pathology, next generation scanning, COVID-19, vaccine, cancer, SARS-CoV-2, analgesic, pain relief, glioblastoma, Systemic Lupus Erythematosus (SLE), obesity, multiple myeloma, CAR-T, immunotherapy

Table of Contents

Recent Advances Fuelling Life Sciences, Health & Wellness

  • Dyskinesia Drug Enters Phase II Clinical Trial
  • Enabling a Groundbreaking Cure for Dyskinesia
  • Deep Learning AI Driving Broad Digital Pathology Fields
  • Opportunities Across Industries/ Applications
  • Next Generation Scanning for Whole Slide Imaging
  • Transforming Digital Pathology across Europe
  • Cloud-based, Seamlessly Integrated Telepathology
  • Improving Clinical Diagnostics
  • Open, Multi-vendor, End-to-end Digital Pathology Solution
  • Transforming Digital Pathology with Cancer Therapy
  • Developing COVID-19 Vaccine Using Tobacco Leaves
  • Preventing COVID-19
  • Repurposing of Cancer Drug Acalabrutinib for the Treatment of COVID-19
  • Acalabrutinib Likely to Improve COVID-19 Management
  • Technology Attributes
  • Opportunities Across Industries/ Applications
  • Non-opioid Analgesic for Post-operative Pain Relief
  • Non-opioid Analgesic for Post-operative Pain Relief
  • Drug to Prevent Kidney Damage from Systemic Lupus Erythematosus
  • Opportunities Across Industries/ Applications
  • Blood Filters to Stabilize Hemodynamics
  • Blood Filters for COVID19
  • Nanoparticles to Reduce Stress
  • Nanoparticles to Reduce Stress
  • CAR-M Therapy for the Treatment of Ovarian Cancer
  • CAR-M Therapy for the Treatment of Ovarian Cancer
  • Re-growing Muscles Using New Innovations
  • Re-growing Wounds Using New Innovations
  • Niacin to Treat Glioblastoma
  • Niacin to Treat Glioblastoma
  • Advances in Treating Multiple Myeloma Using CART- Cell Therapy
  • Targeting CD229 for Multiple Myeloma Treatment
  • New Drug to Treat Obesity
  • Small Molecule Targeting Gut Microbiome
  • Peptide Therapeutics for COVID-19 Treatment
  • Peptide Therapeutics for COVID-19 Treatment
  • The mRNA-based Vaccine for COVID-19
  • The mRNA-based Vaccine for COVID-19
  • Unique Nucleic Acid-based Vaccines and Therapeutics
  • Unique Nucleic Acid-based Vaccines and Therapeutics
  • Groundbreaking DNA Immunotherapy Platform
  • Groundbreaking DNA Immunotherapy Platform
  • Recombinant Enzyme: A Potential Therapy for COVID-19
  • Recombinant Enzyme: A Potential Therapy for COVID-19
  • High Performance Aerosol Drug Delivery
  • High Performance Aerosol Drug Delivery
  • Three Gene-specific Detection of SARS-CoV-2
  • Three Gene Specific Detection of SARS-CoV-2
  • Novel Antiviral and RNAi Medicines
  • Novel Antiviral and RNAi Medicines
  • Activating Innate Immune Response to Fight COVID-19
  • Activating Innate Immune Response to Fight COVID-19

Industry Influencers

  • Key Contacts
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses recent innovations in life sciences, health & wellness. The research encompasses recent advances across digital pathology, COVID-19 management, cancer treatment, pain therapy, and an obesity drug among several other innovations. The TOE also provides valuable growth opportunities within each innovation landscape. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Dyskinesia, artificial intelligence, digital pathology, next generation scanning, COVID-19, vaccine, cancer, SARS-CoV-2, analgesic, pain relief, glioblastoma, Systemic Lupus Erythematosus (SLE), obesity, multiple myeloma, CAR-T, immunotherapy
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-13-00-00
Is Prebook No
Ti Codes D759